FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
Российский кардиологический журнал, 2015 Anticoagulation treatment is a vital component of acute coronary syndrome treatment. Selection of the most efficient and safe drug for the acute coronary syndrome patients without ST elevation (NSTEACS) depends on the strategy of treatment and is in fact
G. V. Mardaryan, S. A. Abugov
doaj +1 more source
The role of a malignancy in the treatment of a venous thromboembolism and superficial thrombophlebitis [PDF]
, 2017 Cancer patients have a manifold risk of suffering from both thrombotic events and anticoagulation-related bleeding complications. For this reason, knowledge of their adequate medication is crucial.
Taanila, Anette
core
Thromboembolism After Intramedullary Nailing for Metastatic Bone Lesions. [PDF]
, 2015 BACKGROUND: The risk of venous thromboembolism (VTE) in patients undergoing intramedullary nailing for skeletal metastatic disease is currently undefined.
Abraham, John A +8 more
core +2 more sources
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: O uso combinado de agentes antitrombínicos, antiplaquetários e estratégias invasivas na síndrome coronariana aguda sem supradesnivelamento do ST (SCAsSST) reduz eventos cardiovasculares. O fondaparinux demonstrou equivalência à enoxaparina na
Camila Pepe +3 more
doaj
Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]
, 2007 Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.) +3 more
core
Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients. [PDF]
, 2012 SummaryAnticoagulation therapy for the prevention of venous thromboembolic events is indicated in patients after major orthopaedic surgery and in hospitalised acutely ill medical patients, who have a high or moderate risk of venous thromboembolism (VTE),
Ageno W, Spyropoulos AC, Turpie AG
core +1 more source
Acute Coronary Syndromes: Management and Secondary Prevention [PDF]
, 2018 Acute coronary syndromes represent a broad spectrum of ischemic myocardial events including unstable angina, non-ST elevation myocardial infarction and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. They
Wenaweser, Peter, Windecker, Stephan
core
BMC SurgeryObjectives To compare the efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism (DVT) in lower extremities after total hip arthroplasty (THA) and total knee arthroplasty (TKA).
Xiang Gao +5 more
doaj +1 more source
Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra)
Journal of Applied Hematology, 2016 Background: Fondaparinux (Arixtra) a synthetic pentasaccharide that causes an antithrombin III-mediated selective inhibition of factor Xa. The clearance of fondaparinux reduces in patients with renal impairment, and there are no dosage adjustments ...
Hend H Metwali +6 more
doaj +1 more source
Management of anticoagulant-related intracranial hemorrhage: An evidence-based review [PDF]
, 2014 The increased use of anticoagulants for the prevention and treatment of thromboembolic diseases has led to a rising incidence of anticoagulant-related intracranial hemorrhage (AICH) in the aging western population. High mortality accompanies this form of
Keyrouz, Salah G, Ray, Bappaditya
core +3 more sources